Trial intelligence / Profile preview

N-acetylcysteine adjunctive treatment in early-onset psychotic episodes

2012-005435-87Phase 3Active

Sponsor
Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón
Start
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Schizophrenia Spectrum Disorders (SSD) comparing N-acetylcysteine adjunctive treatment with Placebo adjunctive treatment (2 arms). Started Dec 2012; status: active.

02

Drugs

acetylcysteine
03

Conditions

Schizophrenia Spectrum Disorders (SSD)

Beyond the preview

Go deeper on 2012-005435-87.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005435-87.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call